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1. Introduction 
      Nanoparticles may provide advanced biomedical 
research tools based on polymeric or inorganic 
formulations or a combination of both. They have 
the potential to be used in many different biological 
and medical applications as in diagnostic tests assays 
for early detection of diseases, to serve as tools for 
noninvasive imaging and drug development, and to be
used as targeted drug delivery systems to minimize 
secondary systemic negative effects. 
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 Nanoparticles used in biomedical applications include liposomes, 
polymeric micelles, block ionomer complexes, dendrimers, inorganic and 
polymeric nanoparticles, nanorods and quantum dots. All have been tested 
pre-clinically or clinically for targeted drug and gene delivery and as agents 
to enhance diagnostic imaging output like in MRI [1,2,3]. Properties present 
only on the nanoscale level, like the increased intensity of fluorescent light 
emission of semiconductor crystals (quantum dots) or switchable magnetic 
properties of superparamagenetic nanoparticles (SPIONs), make these 
materials unique and useful for applications in the biomedical field of 
medical imaging and cell tracking. Other nanoparticles like water-soluble 
synthetic polymers (dendrimers) were tested in pre-clinical models for the 
delivery of drugs, genes, and as imaging agents showing a rich versatility for 
tailoring their binding properties to several requirements, among them 
facilitation of cellular uptake of drugs (e.g. cancer drugs) [4,5,6].    
 SPIONs belong to the class of inorganic based particles having an iron 
oxide core coated by either inorganic materials (silica, gold) and organic 
materials (phospholipids, fatty acids, polysaccharides, peptides or other 
surfactants and polymers) [7,8,9]. In contrast to other nanoparticles, their 
magnetic properties, based on their inducible magnetization, allow them to be 
directed to a defined location or heated in the presence of an externally 
applied AC magnetic field. This  characteristics makes them attractive for 
many applications, ranging from various separation techniques and contrast 
enhancing agents for MRI to drug delivery systems, magnetic hyperthermia 
(local heat source in the case of tumor therapy), and magnetically assisted 
transfection of cells [10,11,12,13]. Research with SPIONs has already 
demonstrated that these particles have the potentional become an important 
tool for enhancing magnetic resonance contrast. SPIONs coated with organic 
molecules showing an overall median diameter of less than 50 - 160 nm are 
available on the market or in final clinical trials as MRI contrast agents for 
detecting liver tumors or to differentiate metastatic from inflammatory lymph 
nodes. SPION functionalized with targeting peptides exhibit an additional 
potential for providing important information for a number of diseases for 
example due to the increased expression of cellular markers. Furthermore, 
they could due to specific adsorption possibly helping physicians to identify 
dangerous arteriosclerotic plaques by MRI [14,15]. The ongoing research is 
directed towards monitoring events on the physiological and molecular level, 
so that inflammatory diseases or tumors can be detected via the accumulation 
of SPIONs or markers expressed on the cell surface [16]. 
 Already marketable products, so-called beads, are micron sized polymer 
particles loaded with SPIONs. Such beads can be functionalized with 
molecules that allow a specific adsorption of proteins or other biomolecules 
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and subsequent separation in a magnetic field gradient for diagnostic 
purposes. More interesting applications, like imaging of single cells or 
tumors, delivery of drugs or genes, local heating and separation of petides, 
signalling molecules or organelles from a single living cell or from a living 
(human) body are still subject of intensive research, whereby the following 
issues are not yet fullly understood:  
 
• The mechanisms utilized by cells to take up multifunctional SPIONs in 
human cells in culture: are there membrane molecules involved?  
• Specific adsorption of SPIONs to targeted subcellular components after 
uptake 
• Transport of drugs, plasmids or other substances to specific cells 
followed by controlled release 
• Separation of SPIONs from the cells after cell-uptake and specific 
adsorption to subcellular components or to biomolecules like proteins 
without interfering with cell function 
• Prevention of uncontrolled agglomeration of modified SPION’s in 
physiological liquids 
• Short and long-term impact on cell functions by loading cells of different 
phenotypes with such nanoparticles 
 
 This book chapter gives a short overview of the research results achieved 
in the last years as well as the research activities in progress, especially in 
regard to SPIONs developed at our laboratory. For completeness and 
thorough understanding of our approach, the information about the physical 
background of superparamagnetism, the behavior of the particle in a static 
(permanent) homogeneous, as well as inhomogeneous magnetic field, and the 
heating in alternating magnetic fields is important in this context. The 
synthesis of these nanoparticles, the choice and fabrication of their coating 
and functionalization indispensible and responsible for the properties and 
biological behavior of the nanoparticles will be discussed and, last but not 
least, the variety of applications in which the authors are performing their 
research will be reviewed. 
 
2. Superparamagnetic particles 
2.1. Superparamagnetism 
 Magnetic materials encompass a wide variety of materials and are 
classified in terms of their magnetic properties and their uses. They are 
classified by their susceptibility to magnetic fields into diamagnetic materials 
with weak repulsion from an external magnetic field (negative susceptibility), 
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paramagnetic materials showing small and positive susceptibility, and 
ferromagnetic materials which exhibit a large and positive susceptibility to 
magnetic fields and are known as magnets in the daily life (“horseshoe 
magnets”). In the first two categories the magnetic properties do not persist if 
the external magnetic field is removed, while for ferromagnetic materials, 
which exhibit strong attraction to magnetic fields, these properties are stable 
even after removal of the external field.   
 If a sufficiently large magnetic field is applied, the spins within the 
material align with the field. The maximum value of magnetization achieved 
in this state is called the saturation magnetization, MS. As the magnitude of 
the field decreases, spins cease to be aligned with the field and the total 
magnetization decreases. In ferromagnets, a residual magnetic moment 
remains at zero field. The value of the magnetization at zero field is called the 
remanent magnetization, MR. The magnitude of the field that must be applied 
in the negative direction to bring the magnetization of the sample back to 
zero is called the coercive field. Changes in magnetization of a material occur 
via activation over an energy barrier. If the number of atoms per particles is 
decreasing, the interaction energy (exchange energy) could reach values as 
low as the thermal energy kBT at room temperature. This leads to a 
spontaneous random orientation of the magnetic spin inside the particles, or 
in other words, the remanence magnetisation as well as the coercitivity will 
be zero. This means no hysteresis and therefore paramagnetic behaviour. 
Such a behaviour could be observed at sizes < 20 nm for iron oxide γ Fe2O3; 
Maghemite) or at 3 nm for pure iron. The saturation magnetisation reaches 
values of 90% of the bulk ferromagnetic material. This lower value is 
explained by the magnetically inactive first atomic layer at the surface of the 
particles. This layer, also existing in bulk material, has a non-negligible 
volume in small particles. The superparamagnetic behaviour is characterised 
by a typical relaxation time τ; the time which the systems need to achieve 
zero magnetisation after an external magnetic field is switched off: 
 
0. ( )
B
KVexp k Tτ τ=                         (1) 
 
where τ0 is the characteristic time (10-9 s),  K is the anisotropy energy (20’000 
J/m3 for iron oxide) and V the volume of the particle: κB is the Boltzmann 
constant, T is the temperature. 
 Another effect which occurs only in such small sized crystallites is the 
presence of energy absorption in superparamagnetic particles due to Néel 
relaxation. If the magnetic domains, fixed within the particles, are directed to 
an alternating external magnetic field, the magnetic dipole moments of the 
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nanosized crystals have to be reoriented very quickly depending on the 
frequency and magnetic strength of the applied magnetic field, the size of the 
particles as well as the environmental temperature. The loss power of the 
particles is used to heat the surrounding environment, e.g. a tissue.  
 
2.2. Physical properties of  SPION 
 In this chapter, the behaviour of the particles in static (permanent) 
homogeneous as well as inhomogeneous magnetic fields and the heating in 
alternate magnetic field will be presented. Also, the colloidal properties of 
nanoparticles will be shortly discussed. 
 In a permanent magnetic field, the particles will be magnetized up to 
saturation magnetization. Each particle is a single domain magnet which 
influences the local magnetic field. This leads to a magnetic dipole-dipole 
interaction between the particles in such a manner that the particles are aligned 
following the field lines of the permanent external magnet. Perpendicular to the 
aligned magnetized particles a repulsive force exists. Because the attractive 
force depends on the number of particles in the chain, normally not more than 
50 to 100 particles built-up a chain in the liquid (Fig. 1). 
 In a permanent magnetic field which shows a filed gradient in z 
direction, a force Fm is acting on the magnetized particles: 
 
 
 
Figure 1. Magnetic beads (1 µm) in a permanent magnetic field with a low field 
gradient. 
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where rm is the radius of the magnetic part of the particle, M the 
magnetization of the particle and B the magnetic flux. This magnetic force 
leads to an acceleration of the particles in the direction of increasing field 
strengths. In a liquid, the movement is hindered by a viscous drag (stoke 
Force, Fs), expressed by the following equation: 
 
6s hF r vπη=                          (3) 
 
where ν is the viscosity of the liquid, rh is the hydrodynamic radius of the 
particle and v is the velocity of the particles. It important to note that the 
hydrodynamic radius of the particles could by much larger than the magnetic 
diameter of the particles, this is especially the case if the particles are coated 
with polymers and proteins (typical values: rm = 5nm, rh > 20 nm). In the 
steady state, Fm=Fs, the velocity of the particles can be calculated easily. A 
typical velocity in a gel type environment is 2 µm /min. 
 In an alternating magnetic field at low frequencies (1 – 100 Hz), the 
particles can follow the changing forces and a rotational or oscillating 
movement is initiated. More interestingly are frequencies between 100 kHz 
and several Mhz. For these frequencies, the magnetic dipole is changing, 
inducing a change in the local magnetic field. Because the magnetic dipole 
can not follow the external magnetic field changes without a time lag (see 
relaxation time equation 1) the complex part of the susceptibility is increasing 
and not negligible. This complex part leads to a loss of magnetic energy and 
heats up the particles and environment. Two type of relaxation exists in the 
field of nanoparticles: Brownian relaxation where the particles rotate, or the 
Néel relaxation. In the latter case the particles are fixed and the direction of 
magnetization inside the particles are changing. For particles smaller than 20 
nm, only the Néel relaxations is of importance. Fig. 2 shows the loss power 
as calculated using equation 4. 
 
2
2
( )
2 (1 )B
mHP
k TV
ωτ
τ ω τ2= ⎡ ⎤+⎣ ⎦  
,  with ω = 2πf.                                                       (4)
 
 
The maximum loss of power could be reached with small particles and high 
frequency. 
 Besides the magnetic properties, the colloidal properties are of high 
importance, especially if the particles are intended for an application in  
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Figure 2. Loss of power as function of particle size and frequency of the applied 
alternate magnetic field. 
 
physiological fluids. The attractive van der Waals force is always present and 
of a constant value, whereas the repulsive forces, like electrostatic or steric 
forces, depends strongly on the ionic strengths, pH-value and the type and 
conformation of the adsorbed polymers and biological molecules. According 
to preliminary data of our laboratory, we can say that in cell media and 
similar liquids with high ionic strength the double layer will be very small 
and therefore steric stabilisation is most important. Because no proven theory 
exists for the detailed modeling of the behavior of complex coated particles 
in physiological liquids, we have undertaken first phenomenological 
investigation of the behavior of such particles measuring the agglomeration 
rate in different cell media with serum or without serum.  
 
2.2.1. Properties of nanoparticles in different biological solutions 
 The stability of nanoparticles is not only dependent on the coating itself 
but how it relates to the biological environment. Particles can agglomerate 
through contact with proteins and by this may provoke changes regarding cell 
internalisation or attachment and cytotoxicity. Turbidity measurement and 
photon correlation spectroscopy (PCS) have been used to examine the 
agglomeration of Polyvinyl alcohol coated nanoparticles (PVA-SPION) 
Vinyl alcohol/vinyl amine copolymer coated particles (A-PVA-SPION), and 
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those coated with polyethylenimine (PEI-SPION).  While uncoated SPIONs 
agglomerate immediately in PBS and biological fluids, the investigated 
polymer coated SPIONs were absolutely stable in water and in PBS for 
months and over a pH range of 3–11 without showing any signs of 
agglomeration. However, using such particles in cell media such as RPMI 
and DMEM, both in presence and absence of 10% fetal calf serum (FCS), 
changes the behaviour of the particles and lead to different agglomeration 
behaviour when the particles are exposed to such media for more than 30 
minutes.  The A-PVA-SPIONs with a mean diameter of 40 nm (as all other 
SPIONs used in this investigation) showed in DMEM supplemented with 
FCS their initial size up to nine days (maximum time observed). A-PVA-
SPIONs. used in DMEM only showed a stable particle size during the first 
hour but increased their diameters up to 110 nm after 2 h.  PEI-SPION beads 
agglomerated immediately in the presence of fetal calf serum whereas they 
remained stable in all media without FCS and no change in the turbidity and 
bead size could be observed within 2 h [17]. The agglomeration behavior of 
nanoparticles in simulated body fluids as well as the knowledge on cell 
viability (cytotoxicity) for different cells determines the use of these particles 
for in-vivo application.   
 
2.3. Materials and synthesis  
2.3.1. Synthesis of coated SPION 
 Synthesis and coating of nanoparticles becomes a determining step in the 
further use of nanoparticles in-vivo and in-vitro. The potential toxicity of 
such material is not only related to their nanosize nature but especially to 
their surface properties, which is the determining factor for cellular uptake 
and cytotoxicity, whereas the type of particle does not seem to play such an 
important role [see 17Fink et al.].    
 The colloidal stability and behaviour of nanoparticles in suspensions can 
be tailored and is related to the pH, additives in the solution as in cell media 
or body fluids, their viscosity and any other fluidic properties. Long range, 
attractive van der Waals forces are ubiquitous between such nanoparticles 
and must be balanced by Coulombic, steric, or other repulsive interactions to 
engineer the desired degree of colloidal stability. Beside a long term stability 
demanded for nanoparticle suspensions for use in biomedical applications, 
guarantees for a high quality in the particle production like small particle size 
distribution and constant coating properties are required. In a second step, the 
nanoparticles have to be tailored to render their performance in a specific 
biological environment, i.e. either to attach or to enter cells in case of drug 
targeting, gene transfection or for long time persistence within the blood 
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stream for MRI applications (blood-pool contrast agent). An overview on 
some current polymer coating materials is shown in the article of A.K. Gupta 
and M. Gupta, 2005 [see Ref 11], as well as other references dealing with 
different other polymer coatings among which are polysaccharides (dextran, 
starch and chitosan) [18,23], polyvinyl alcohol [19,20], poly(l-lysine) (PLL) 
[see Ref 3], starch derivatives with phosphate groups to bound mitoxantrone 
as chemotherapeutikum [21], and inorganic coatings like silica, or gold.  All 
these coatings serve for further derivatization of the particles by ligands, such 
as peptide sequences conjugated to the nanoparticle surface to facilitate 
receptor-mediated endocytosis or phagocytosis, or proteins and antibodies to 
bind to biological receptors [25]. 
 The commonly used multi-step liquid phase synthesis of SPIONs is time 
consuming and laborious because each additional reaction on the particle 
surface is followed by a purification step such as magnetic sedimentation, 
size exclusion chromatography, or dialysis. In addition, repeated magnetic 
sedimentation of the SPIONs may cause irreversible agglomeration of the 
nanoparticles. Although ultrasonication is often applied to dissociate the bead 
agglomerations, it may cause damage to the bound bio-active molecules, 
resulting in an overall decrease of their biological activity. The use of size 
exclusion chromatography in repeatedly multi-step modification results in 
dilution of the particles upon each purification step and in a loss of particle 
on the column. 
 In order to bypass the need for repeated purification and to assure 
continuous working processes, we immobilized SPIONs as a stationary solid 
phase in a column by a high gradient permanent magnetic field. For 
functionalization of the immobilized particles during solid phase synthesis, 
the chemical reagent is conducted over the SPIONs as solid support. 
Although solid phase synthesis on polymer support is widely described, to 
our knowledge the solid phase multi-step biofunctionalization of SPIONs in a 
magnetic fixed bed reactor has never been shown. 
 In this magnetic fixed bed reactor the immobilization of the magnetic 
particles is based on the attractive force exerted by a magnetic field gradient 
(Fig. 3.) We have developed a fixed bed reactor with a quadruple arrangement 
of magnets for the (bio)-modification of SPIONs. The immobilisation of 
SPIONs onto the fixed bed reactor and the subsequent functionalization of 
SPIONs are shown by different examples. We demonstrated that surface 
derivatization on SPIONs was made directly within this setup (Fig. 4). 
 Our data indicated that the efficiencies, product qualities, the low 
agglomeration, and recovery rates of the functionalized nanoparticles 
produced by solid phase synthesis were superior to those obtained by synthesis 
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Figure 3. Layout of the reactor for coating SPIONs. 
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Figure 4. Structure of a typical SPION particle coated with a polymer, functional 
groups, linkers, fluorophors and peptides. 
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in the normal liquid phase. Such equipment allows for a semi automated 
coating of SPION including in-situ synthesis of peptides.  
 
3. Applications in the biomedical field 
 The transdisciplinarity of basic and translational research carried out in 
nanotechnology during the last decades lead to a broad field of novel 
applications for nanoparticles; those for iron oxide particles with various 
coatings has been practiced for nearly 40 years in in-vitro diagnostics [26]. 
However novel biomedical fields of in-vivo applications further challenge 
nanoparticle development because of their double role: they are small enough 
to be transported within the blood stream or lymphatic system, but they may 
be attached to cells or even enter a cell and be transported by cells. If 
combined with drugs or genes, these particles may change the viability of or 
the transcription processes in cells which render them interesting for the 
pharmaceutical industry and for cell biology. But it raises the question about 
secondary effects of these particles on their passage through the human body. 
Nanoparticles have to be highly specific, efficient, and should be rapidly 
internalized by the target cells, which is limited by several factors [27] [see 
also Ref 21]: “(i) nanoparticle aggregation (nanoparticles have a large 
surface/volume ratio and tend to agglomerate); (ii) the short half-life of the 
particles in blood circulation (when nanoparticles agglomerate, or adsorb 
plasma proteins, they are quickly eliminated from the bloodstream by 
macrophages of the mononuclear phagocyte system before they can reach the 
target cells); (iii) the low efficiency of the intracellular uptake of 
nanoparticles; and (iv) nonspecific targeting.” The coating and 
functionalization of such particles described in the last section is therefore 
decisive for their specific application and their biocompatibility in the human 
body. 
 
3.1. Imaging 
 For many years, supermagnetic nanoparticles have been used in 
diagnostics as contrast agent in magnetic resonance imaging (MRI) and 
magnetic resonance angiography (MRA) [28,29,30]. To fulfill the 
requirements of improved enhancement, the substances used must be 
magnetically active. Negative enhancers - like most of the diamagnetic 
materials - have only a negligible effect on the MR signals. Instead, 
paramagnetic materials, like different compounds containing iron or 
lanthanide or ions like (gadolinium, manganese, dysprosium,) show positive 
enhancement by due to their unpaired electrons resulting in a positive 
susceptibility.  They shorten the longitudinal relaxation time T1, while e.g. 
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dysprosium predominantly shortens the transverse relaxation time T2. The 
large magnetic moment of SPIONs at sizes of 5 to 10 nm creates large 
magnetic field heterogeneity through which water molecules diffuse by 
inducing dephasing of the proton magnetic moments that forms the data for 
MR images [31]. These SPIONs are mostly used because of their negative 
enhancement effect on the T2 relaxation time. The transport of most of the 
contrast agents is by intravenous administration, which determines the size of 
the nanoparticles. For successful delivery, the particles have to pass through 
the vascular capillary wall. While e.g. Gd ion – polymer complexes are of 
small size (≤ 10 nm), the size of the coated SPIONs can be up to 100 nm and 
the delivery of these nanoparticles to the targeted tissue is more problematic. 
Depending on their size, charge and the configuration of the coating these 
particles are metabolized by the reticuloendothelial system (RES) consisting 
of monocytes and macrophages. These cells accumulate in lymph nodes and 
the spleen as well as in the liver (Kupfer cells) and are favored for the uptake 
of SPIONs and influence the delivery time and the diffusion to certain 
tissues. Smaller particles generally circulate longer and are taken up by cells 
of the lymphatic system and bone marrow while particles > 50 nm are taken 
up by liver cells [32]. If particles are not entirely captured by the liver and 
spleen, they are widely evaluated as potential marker of inflammation for the 
diagnosis of inflammatory and degenerative disorders associated with high 
macrophage phagocytic activity like for plaque imaging or brain ischemia 
[33], [see Ref 14]. SPIONs are used in tumor detection, as the tumor lesions 
exclude the uptake of particles (tissue in MRI remains bright) while the 
macrophages in the normal liver tissue will take up the particles and darken 
the image of the tissue [34]. Other applications in MRI are the use of such 
particles to track stem cells transplanted into organs such as brain or to 
demonstrate macrophage activity within atherosclerotic plaque [35].   
 
3.1.1. Imaging of atherosclerosis  
 Research on the use of SPIONs for the detection of atherosclerotic 
plaques by MRI has been undertaken by the Powder Technology Laboratory, 
Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland in 
collaboration with the Department of Cardiology and Angiology, University 
of Freiburg, Freiburg, Germany. Monocytes, as precursor cells of 
macrophages, promote atherosclerosis by secreting mediators and are in 
highly active state of phagocytosis and secretion of cytokines and 
chemokines. Before the rupture of atherosclerotic lesions, they show an 
accumulation of macrophages. The phagocytosis of SPIONs by macrophages 
may therefore act as a potential marker of inflammation for plaque imaging. For  
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this study, MAC-1 expressing chinese hamster ovary (CHO) cells, expressing 
MAC-1 either in a native, low affinity state (wildtype, WT) or a high affinitiy 
state (GFFKR-deleted cells, DEL) were used to simulate the type of activated 
macrophages found in atherosclerotic plaques. CHO-cells not expressing 
MAC-1 were used as controls (NCHO). These cells were grown for 24 h at 
38°C in a cell incubator, washed and then either incubated with or without 
CD11b-blocking monoclonal antibody 2LPM 19c and finally amino PVA-
SPIONs were added to the cells and incubated for another 24 hours. Cell 
growth and viability was not influenced by the incubation with SPIONs (details 
of the study are shown in ref. 14). Those cell lines expressing the MAC-1–
receptor showed higher signal values compared to natural CHO cells, and the 
activated receptor in the DEL cell lines raises the signal extinction in a 
significant manner. It can also be shown that MAC-1 expressing cells 
incubated with CD11b-antibody constantly show lower signal extinction than 
those without CD11b-antibody. The studies identified the integrin MAC-1 (CD 
11b/CD18) as a mediator for the superparamagnetic iron oxide nanoparticles to 
endocytose into monocytes/macrophages and showed that MAC-1 is also a 
central mediator of inflammation. Dextran-coated particles, which are mostly 
used as contrast agents, are commonly attached to cells but not taken up by 
them, while SPIONs coated with amino-functionalized polyvinyl alcohols 
interact with different cells [see also Ref 19] [36] and therefore underline a 
receptor based uptake of SPIONs by cells, which could be further supported 
through these experiments.  
 
3.2. Drug delivery and gene transfection 
 The research on targeted drug delivery and gene transfection is motivated 
by the clinical need for a selective targeting of drugs and improved precise 
control of drug delivery kinetics, especially for drugs with low 
bioavailability, therapeutic indices, solubility and circulating half-time. 
Nanoparticles are very promising in this respect, particularly those with a 
hydrophilic surface because they can escape the uptake macrophages and 
reticuloendothelial systems (RES) in tissue and the lymphatic and blood 
system. The particles can also be functionalized by a biological molecule to 
be recognized as signal for targeted cells. This can be accomplished by using 
the unique properties of superparamagnetic iron oxide particles only available 
in their nano-scale structures. The polymeric coating component in overall 
development provides versatile chemical functionalization to optimize both 
drug delivery dosage regimens for local drug therapy and the ligands for 
targeting modes as well.   
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3.2.1. Drug delivery 
 The use of magnetic particles in the treatment of cancer is less focused 
on the delivery of drugs and more on their use as a new therapeutic concept 
in which tumor cells are damaged by applying local heat through an external 
magnetic field. This application called hyperthermia will be discussed in 
chapter 3.5.1. Other aspects of cancer treatment is the early detection of 
metastasis of tumor cells, which involves nearly half of all cancers, and the 
occurance of toxic side effects on systemically given anti-cancer 
chemotherapeutics. Using targeted drug delivery vehicles like nanoparticles, 
this shortcoming may be overcome as the drug will be carried directly to the 
tumor site which limits the exposure time to healthy tissue and organs and 
may also protect these drugs from early biodegradation. A further 
requirement for safe use of such targeted drug delivery is to target drugs to 
specific body sites and control the release of drugs for prolonged periods of 
time. The review on anticancer agents based on nanoparticles by Zamboni 
[37] gives a nice overview of agents which are used today or which are in 
further development. Most of them are based either on liposomes, so called 
nanosomes, dendrimers and nanospheres as subclass of nanoparticles. All 
these materials and formulations are chosen to provide a selective delivery of 
conventional and new genetic drugs [38], to preferably accumulate in tumor 
tissues and show a better solubility combined with a defined release protocol, 
as well as to have the potential to overcome resistance associated with the 
regular anticancer agent. Several nanobased drugs are already approved, 
others using new genetic based drugs like plasmid DNA-containing 
therapeutic genes, antisense oligonucleotides, and small, interfering RNA 
[siRNA] are still under development [39]. Magnetic nanoparticles, which can 
also be bound to drugs, have an additional value as they can be trapped at the 
target site by an external magnetic field. The hope that injecting magnetic 
nanoparticles combined with the targeting molecules, such as proteins or 
antibodies, and to direct them to any cell, tissue or tumor in the body is 
unrealistic today as the magnetic force is not high enough to guide the 
particles through the blood system. However, if used with cell specific 
molecules like other nanoparticle based formulations, these magnetic 
particles have the additional function to be visualized by MRI in the targeted 
tissue. This function helps not only for early detection but also in view of 
personalized medicine.  
 
Drug delivery in joint diseases 
 Magnetic drug targeting using superparamagnetic iron oxide particles 
(SPION) as carrier systems is attractive for the application in those parts of 
the body accessible with targeting magnetic fields showing locally high field 
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gradients. Therefore, SPIONs have been developed for therapy of joint 
diseases in human and animals. Conventional systemic and/or intraarticular 
therapies are normally associated with negative side effects of the drugs, such 
as nephrotoxicity, hepatic and gastric problems, especially in cases where 
prolonged therapy is necessary. But problems also arise with short term 
applications, such as the inability to maintain effective drug concentrations 
within the joint due to increased production of synovial fluid, its more rapid 
filtration through the joint membrane and eluation into the vascular system. 
Therefore the aim is to increase the residence time of SPION through the 
application of high magnetic field gradients in the joint area by applying 
extracorporal magnets. Additionally protracted drug release could be 
achieved using functionalization with conjugated drug formulations. This 
combination could be the preferred method of choice for therapeutic 
application in chronic and acute joint affections (eg. synovitis, intraarticular 
trauma, rheumatoid arthritis, etc.). The goal of our consecutive studies in 
sheep was a “proof of principle” that intraarticular application of 
functionalized SPION is possible, safe and that the use of extracorporal 
magnets enhances their effect in situ.  
 Tissue involved in joint disease mainly consists of synovial membrane, 
capsular tissue, hyaline cartilage and subchondral bone, where synoviocytes, 
chondrocytes and osteoblasts play a major role. These cells originate from the 
mesoderm in embryogenesis and, depending on the environment, will 
differentiate into their final cell lineage. Chronic inflammation may lead to 
de-differentiation (e.g. fibrous tissue) which is normally associated with loss 
of function, which is detrimental to the overall functionality of the joint. 
Hyaline cartilage degenerates into fibrocartilage and bone resorption and 
additionally osteophyte formation changes the bone structures of joints. 
Furthermore, excessive fibrosis of the fibrous capsule and within the joints 
occurs, incapacitating normal joint function through limitation of flexion and 
extension. Therefore, it was important to clarify biocompatibility issues of 
SPION before they could be applied in living animals. Furthermore, if animal 
experiments were to be conducted, a reliable detection system had to be 
developed to track the particles within the joint itself as well as systemically. 
This was also important to study their distribution and elimination from the 
body system concerning safety issues. 
 In preliminary experiments with ovine synoviocytes, chondrocytes and 
osteoblasts, it was shown in routine cell cultures that plain polyvinyl alcohol 
coated SPION obtained by classical co-precipitation in water (Mowiol®, 
MW 12,000, Clariant) at a concentration of 5 mg/ml were well tolerated by 
synoviocytes, chondrocytes and osteoblasts and no up-regulation of 
inflammatory mediators occurred. Cellular uptake of SPION could be well 
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detected with special iron stains using Prussian Blue (Fe3+) and Turnbulls 
(Fe2+). SPION up-take over time was enhanced over time if magnets were 
placed under the cell culture vials for 12 hours (magnetic flux density 220mT 
at cell level, magnetization of particles 35Am2/kg). Cell viability at this 
concentration was 98% in all cell types and cell morphology was normal if 
plain PVA coated SPIONs were used. The main cellular up-take of SPION 
took place between 12 and 48 hours, when the cytoplasm was full with 
slightly aggregated SPION while still maintaining normal cell morphology. 
Detection of SPION using the special stains was reliable if compared to 
controls incubated without particles. While up-take was similar in 
synoviocytes, chondrocytes and osteoblasts, sensitivity was highest in 
synoviocytes when different concentrations of amino-vinyl amine copolymer 
PVA coated particles were used.  
 In a next step, functionalization of the PVA-vinyl coated SPION with 
fluorescence dyes was successfully performed and cellular up-take in 
synoviocytes repeated. The fluorescence dyes Cy3.5 and PVA-Texas Red 
were used in vitro. Synoviocytes, as the most sensitive cell types, were again 
chosen for proof of principle to deliver functionalized particles to the 
cytoplasm. With these experiments, it was demonstrated that functionalized 
particles were also taken up by synoviocytes and that external magnets 
enhanced delivery (NdFeB-permanent magnet, remenance field 1.3T, 
magnetic field at cell area 100 mT, field gradient 7T/m). Cy3.5 proved 
superior to Texas-Red for confocal microscopy, where cells were 
counterstained with Hoechst 33342 showed that nuclei were tightly 
surrounded by functionalized particles within the cytoplasm, but no SPION 
penetrated the nuclear membrane. Uptake was seen as early as 3 hours after 
incubation and, as with plain PVA-coated SPION, at 24 hours most of the 
cytoplasm was filled with fluorescent particles (Fig. 5). Flow cytometry 
confirmed macroscopical findings, that the majority of cells (ca. 82%) were 
positive for fluorescent signals.  
 With these results, in vivo experiments with intraarticular application of 
plain and with Cy3.5 functionalized particles were conducted. PVA-coated 
and amino-PVA Cy3.5-SPION at a concentration of 5 mg Fe/ml were 
injected into carpometaphalangeal (1.0 ml) and stifle joints (2.0 ml) of sheep 
under anesthesia. Tests were performed with and without extracorporal 
magnets (NdFeB-permanent magnets, 1.3T) to test their influence in vivo 
(Fig. 6). The magnets were placed in pockets of specially designed bandages 
that were additionally sutured to the skin at the lateral (stifle) or dorsal 
(carpometaphalangeal) aspect of the joints. Similar to the in vitro experiments, 
uptake of SPION was followed over time and sheep were sacrificed at 3, 24, 72 
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Figure 5. SPIONs labeled with Cy3.5 taken up by cells (microglia) can be visualized 
by confocal microscope (Photo: McGill University, Montreal, Canada). 
 
 
 
Figure 6. In vivo setup: Particles were injected in the joint of the sheep and were 
maintained at injection site by permanent magnets (blue pouches). 
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and 120 hours after injection (Fig. 7 and Fig. 8). Results demonstrated good 
biocompatibility of both plain and amino-PVA Cy3.5 SPION, although the 
latter showed a mild inflammatory reaction within the synovial membrane, 
which subsided in all instances at 120 hours. The hyaline cartilage surface 
appeared normal at all time periods. Macroscopical inspection revealed a 
 
 
 
Figure 7.  SPION (Blue) attached and up-taken by synovia cells. 
 
 
 
Figure 8. SPION in the spleen after 72h of injection of the particles into the joint. 
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more local concentration of SPION in the tissue if extracorporal magnets 
were applied. Histologically, cellular uptake of SPION was demonstrated for 
the synovial membrane and joint capsule, but not for chondrocytes of hyaline 
cartilage or subchondral bone. SPION uptake in the intima was increased 
with magnets in place, whereas in the subintimal fibrous tissue (joint capsule) 
concentrations were decreased. Inflammatory responses were minimal, 
peaking at 24 h and were only related to the functionalized particles, where 
the fluorescent dye Cy3.5 was thought to be responsible. Furthermore, if 
magnets were applied, the inflammatory signs were less and more localized. 
Fluorescence within the tissue was more wide spread without extracorporal 
magnets, but more localized if magnets were present. It was highest at 72 and 
120 hours, when most particles had been internalized within the cytoplasm. 
Generally, functionalized particle uptake was less and peaked at a later time 
point compared to plain PVA-coated particles, which was attributed to 
stereometrical hindrance of larger particles and thus, slower uptake.  
 The distribution and elimination of SPION were also followed on a 
systemic level. For this, tissues of the sheep used for the intraarticular 
experiments were harvested from the neighboring inguinal, respectively 
axillary lymph nodes, from the liver, spleen, gall bladder, lungs, kidneys and 
urinary bladder. Samples were prepared for routine paraffin histology and 
stained with hematoxylin eosin (HE) to assess normal histomorphology, and 
Prussian blue as well as Turnbulls to detect SPION within the tissue. SPION 
could be easily detected in histology sections of the lymph nodes, liver, 
spleen and kidneys, but not in the lungs, gall or urinary bladder. No 
histopathological changes were visible in all organ systems. 
 The detection of SPION was also followed over time (3, 24, 72 and 120 
hours) and an interesting distribution pattern was detected. While it was well 
known that SPION were eliminated through the reticuloendothelial system, it 
was never described that SPION were first excreted within the primary urine 
through the glomerular filtration system of the kidneys and then reabsorbed 
in the proximal tubuli, after which they were transported to the liver and the 
spleen. In the liver, SPION were found clearly accumulated in the liver trias 
and in the Kupffer cells, whereas in the spleen mainly they were found in the 
red, but not in the white splenic pulp. Hemosiderin was also stained blue in 
the liver and the spleen. Nevertheless, the difference in staining intensity was 
clear between experimental animals and controls.  
 In conclusion of our experiments, PVA coated and amino-PVA Cy3.5 
SPION were proven suitable as drug carriers for intraarticular use and seem 
attractive for modern treatment modalities in joint disease. Future investigations 
will focus on functionalization of SPION with chondroprotective or – 
modulating drugs. 
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3.2.2. Gene transfection 
 A large number of disorders can be explained or understood with of more 
detailed genetic information, which can then be used either for early detection 
of such diseases or even for their treatment. For more than twenty years, 
methods for targeted delivery of genes have been attempted either by viral or 
non-viral carriers. However the use of viral vectors has its limitations and 
several cases with severe side effects were observed [39]. Three adverse 
events occurred in a human gene transfer study involving  “engraftment of an 
autologous bone marrow derived, CD34+
 
hematopoietic stem cell enriched, 
cell population transduced with a Moloney murine leukemia retrovirus 
derived replication incompetent vector encoding the common gamma chain 
(γc) transmembrane protein subunit shared by receptors for Interleukins 2, 4, 
7, 9, 15 and 21. Three children in this study developed T-cell acute 
lymphoblastic leukemia (T-ALL) almost 3 years after their gene therapy 
treatment.” The US FDA has not yet approved any human gene therapy 
product for clinical application [40]. 
 Even though viral vectors are the only ones successfully expressing 
genes in vivo, such problems mentioned in this former study, which are also 
not based on a single event, show the limitations of the viral gene transfer. 
Furthermore, viral vectors are immunogenic and may result in the production 
of neutralizing antibodies by the host and other inflammatory responses [see 
Ref 40]. Therefore, the development has been strongly focused on nonviral 
tools like nanoparticles complemented with DNA, plasmids or interfering 
RNA (RNAi).  Most of the nanoparticles are positively charged to penetrate 
the cell membrane or need a cell surface membrane receptor that then brings 
the vector inside the cell [41]. Despite many years of research, the poor 
transfection rate in comparison to viral transfection limits the application of 
non-viral gene therapies in vivo. Yi-Yan Yang et al. [see Ref 40], show that 
various natural and synthetic materials can be used and have been further 
developed as non-viral gene vectors, e.g. cationic liposomes, cationic 
polymer and different inorganic nanoparticles like silica based nanoparticles, 
carbon nanotubes or metal nanorods. The authors show that cationic polymer 
nanoparticles are the most attractive because they can be synthesized and 
functionalized depending on the requirements for the different mechanism of 
internalization. 
 
Non-viral gene transfer by SPION 
 After positive results using SPION as carrier system for drug delivery 
into the joint, an attempt was made to use the same nanoparticles as non-viral 
vectors for delivery of DNA or DNA fragments to the joint. For this 
experiment, coating and functionalization had to be adapted. As proof of 
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principle, transfection coding for green fluorescent protein (pEGFP-C2 
plasmid) was performed in vitro using a pulsed magnetic field (0 to 30 mT, 1 
Hz) for enhancing transfection efficiency in several cell lines. In contrast to 
our previous experiments, SPION were coated with polyethylenimines (PEI) 
that were shown reliable for condensing DNA and RNA into stable 
complexes by means of electrostatic interactions and protecting the nucleic 
acids from degradation by cellular polymerases within the tissues. PEI 
polyplexes allows uptake through endocytosis into endosomes that, after 
swelling, burst and release the nucleotide complexes into the cytoplasm, 
whereby the DNA translocates into the nucleus.  
 SPION were prepared by alkaline co-precipitation of ferric and ferrous 
chlorides in aqueous solution as earlier reported [42].  The pEFG-C2 plasmid 
was introduced into Escherichia coli, where DNA was purified using 
Maxiprep pasmid kits (Quiagen). PCR products from pEFG-C2 plasmid were 
amplified using primers designed to include the 5’human cytomegalovirus 
(CMV) immediate early promoter and a 3’SV40 early mRNA 
polyadenylation signal (forward primer; 5’CCG TAT TAC CGC CAT GCA 
T-3’; reverse primer: 5’GCC GAT TTC GGC CTA TTG GT-3’).  
 Primary ovine synovial cells were collected from sheep that were 
sacrificed at the University’s own slaughter facility, isolated and proliferated 
in 2-3 cell passages. HeLa (human cervix carcinoma cells) 293T and Cos7 
(fibroblasts) were commercially available cell lines serving as controls. After 
routine cell seeding and proliferation including cell passages, cells were 
transfected with PEI coated SPION functionalized with DNA (5µg 
DNA/well) resp. PCR products (5µg/well). PEI (20% w/w, diluted 1:1000 in 
PBS, 10µm DNA/well) alone, lipofectamine (Invitrogen, 2.5µg DNA/well) or 
calcium phosphate transfection (10µg DNA/well) served as controls. Cell 
cultures were placed on a static NdFeB permanent magnet for 20 minutes 
(magnetic flux density 250mT, magnetic field gradient 10T/m in the cell 
area), and part of the groups were additionally exposed to a pulsed magnetic 
field (Dynamic Magnetic Field Generator, MatSearch, Switzerland; 
stationary wave of sinus type, max. amplitude 27mT, field gradient 10mT) 5 
minutes before or after placing the vials on the magnetic field. Transfection 
was verified with a fluorescence microscope after trypsination with flow 
cytometry. 
 Transfection was possible with PEI-coated SPION in all cell types 
including ovine synoviocytes (ca. 73.%), but was higher when static magnets 
were applied (7-10 fold increase). When a pulsed magnetic field was created, 
a gradual temperature increase was recorded (37-42.5°) on the surface of the 
generator. Nevertheless, this did not impair cell viability rather, if applied 5 
minutes before the static magnet, it increased transfection rates by up to 8- 
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fold in synoviocytes using PEI-SPION. Increase of transfection in controls 
was considerably less with lipofectamine and calcium phosphate (1.6-1.8 
fold) compared to controls not exposed to magnets. Transfection cells 
including synoviocytes was also possible using PEI-SPION functionalized 
with eGFP PCR-products (1.6 kilobase pairs) with static magnets alone. As 
with plasmids, transfection rates could be still increased when a pulse 
magnetic field was applied beforehand. Further studies confirmed that pulsed 
magnetic field enhances transfection with eGFP plasmids in synoviocytes, 
chondrocytes and osteoblasts in sheep also if other magnetic carriers were 
used. 
 After successful transfections of synoviocytes in vitro using PEI-coated 
and eGFP functionalized SPION, animal experiments in sheep were 
conducted similar to our earlier experiments. PEI coated SPION complexed 
to plasmids encoding for GFP or dsRED and PEI coated particles were 
prepared according to Petri-Fink et al [43].   
 Again functionalized SPION (using 2 DNA concentrations) were injected 
into stifle and carpometaphalangeal joints with the animal under general 
anesthesia. Injection was performed with a static magnet (NdFeB) in place 
for 20 minutes followed by 5 minutes with a pulsed magnetic field. The static 
magnet was then kept in place for 12 hours using the specally designed 
magnet bandages before being removed for good. Animals were followed for 
24, 72 and 120 hours after particle application. Samples of synovial 
membranes were harvested and processed for routine and fluorescence 
histology as described and special stains (Prussian blue, Turnbulls) were used 
for particle detection within the tissue. In addition, immunohistologic 
methods on cryosections were applied using antibodies against GFP. 
 In contrast to our earlier studies in vitro, transfection was not achieved at 
either time period. No fluorescence could be detected neither with GFP nor 
dsRED. Mild inflammatory reactions seen between 72 and 120 hours 
indicated diffuse plasmacytic and lymophocytic infiltration of tissue. 
Inflammatory changes were more pronounced when higher DNA 
concentrations were used. Furthermore, iron particles were infrequently 
observed in synovial membranes by special iron stains independent of time 
periods and despite application of magnets or pulsed magnetic field. 
Immunohistochemistry of the adjacent inguinal lymphnodes yielded few 
positive cells for GFP proteins indicating that transfection had occurred, 
although at a very low level and not as expected in the synovial membrane 
(unpublished data) but within lymph nodes. Further laboratory tests 
conducted at the EPFL demonstrated that PEI-coated SPION complexed to 
plasmids encoded for GFP aggregated immediately if added to fresh synovial  
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fluid. It was attributed to the positive electric charges of the DNA plasmids 
and the highly negative charge of the hyaluronic acid of the synovial fluid. 
This could not be overcome, even if samples were diluted in vitro or rigorous 
joint lavage was performed before the particles were injected into the joint. 
However, this aggregation explained also the stronger inflammatory response 
and influx of macrophages in the stifle and carpometaphalangeal joint of the 
experimental animals.  
 In the framework of the development of new non-viral gene vectors, 
novel DNA fragments (PCR products) were synthesized containing only the 
GFP gene and the 5’human cytomegalovirus (CMV) immediate early 
promoter and a 3’SV40 early mRNA polyadenylation signal (Institute of 
Veterinary Biochemistry and Molecular Biology, University of Zürich). 
When DNA/PEI-SPIONs and DNA/PVA-SPIONs complexes were added to 
cells that were subsequently exposed to permanent and pulsating magnetic 
fields, PEI-SPIONs proved to be very efficient gene vectors, more than the 
conventional non-viral vectors. We could show for the first time that the 
transfection of PCR products containing only the gene of interest, is also 
enhanced by combined use of magnets and SPIONs. (Vetsuisse, 
“Superparamagnetic iron oxide (SPION) nanoparticles for plasmid and 
protein delivery in vitro and in vivo: a feasibility study”). 
 The derivatization of the particles with nucleus targeting peptides allows 
additionally the specific adsorption of the particles at the surface of the 
nucleus (Fig. 9) or as also shown at other targeted organelles.  
 Our results show that 
 
• The SPION DDS has the potential for dual function targeted imaging-
delivery nanosystems and can be locally targeted to specific sites guided 
by externally applied magnetic fields.  
• The SPION remain inactive until application of an external magnetic       
field, triggering local release of drug from the nanoparticles using a 
thermosensitive polymer. Injected nanoparticles coated with drugs can be 
retained at the injected site by external applied magnetic fields where 
drug is released slowly by diffusion through the polymer layer. 
Additionally active drug delivery by promoting the cytosolic delivery of 
particle-drug- nanosystem into the cell where enzymatic action or general 
hydrolysis can release it.  
• The SPION-DDS enables therapeutic and diagnostic effects and thus 
allows for treatment follow-up by magnetic resonance imaging  
• The system can be tailored for in vivo cell targeting, cell internalization, 
and nuclear uptake.  
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Figure 9. SPION Particles derivatized with nucleus targeting peptides at the surface 
of nucleus. (Photo Confocal microscope, A. Finka). 
 
3.3. Effect of Néel relaxation 
 Magnetic nanoparticles coupled with biological substances have gained 
attention in a variety of biomedical applications, mostly based on their strong 
magnetic moment [44]. These particles can induce heat, if a certain 
concentration in an organ is exposed to a magnetic field. This is called 
selective ferromagnetic induced hyperthermia or magnetic fluid hyperthermia 
(MFH). It becomes important in cancer therapy as an additional therapy and 
will therefore significantly help to avoid or to minimize side effects of 
chemical or nucleic therapies In this therapy, cells of a certain type will be 
heated up to about 43°C, at which temperature they will die. The surrounding 
tissue is not involved and therefore this method is much more protective than 
other cancer therapies in which large areas of cells or tissue will be destroyed. 
Nevertheless, problems were also associated with this type of therapy. Often 
the magnetic fields were not strong enough and the magnetic particles were 
too large to give enough heat per unit of particle in the body. Some people 
died of toxicosis because of the high quantity of iron into the body. Much 
empirical work was done in order to manifest a therapeutic effect on several 
types of tumors, and recently clinical tests are carried out by Magforce [45] 
for the treatment of brain and prostate cancer.  
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 For the hyperthermia treatment, magnetite cationic liposomes [46] or 
dextran magnetite complex [47] and thermosensitive magnetoliposomes [48] 
are used. Until now, it was necessary to modify the surface of the core-shell 
particle for medical applications in order to target them to the specific organ.  
 
3.3.1. Hyperthermia  
 Another approach has been made by the authors, in close cooperation 
with the Laboratoire de Pharmacie Galénique, Section de Pharmacie, 
Université de Genève, to overcome problems with the specific cell targeting 
of single particles for certain cancer treatments. Percutaneous injection of 
polymethyl-methacrylate (PMMA) into osteolytic lesions [49], has shown 
tumor cell damage by exothermic effects of the PMMA polymerization. The 
stabilizing effect of PMMA may be helpful in pain relief and the thermic 
reaction has an additional tumoricid effect. After applying a temperature raise 
of 20 °C vertebroplasty tumor necrosis could be observed extending well 
beyond the site of PMMA implantation (B,C). Such short term hyperthermia 
effect due to the PMMA polymerization could be even further improved 
through additional heating due to the interaction of superparamagnetic 
nanoparticles with an external AC magnetic field. Moreover, this effect can 
be easily controlled for long-term and adapted to the needs of cancer therapy. 
Therefore, the authors and in collaboration with researchers at Geneva have 
developed a new concept for hyperthermic treatment using SPION as heat 
source.  For this development, free particles are encapsulated in bone cement 
or another polymer, so that this material will be classified by National Health 
Organisations as a medical device and not as a drug as mentioned in other 
publications. During polymerization, the hardening cement will provide the 
first part of energy for the heating of the tumor. In a second step, the 
superparamagnetic particles will beheated applying an external alternating 
magnetic field.  For particles smaller than 20 nm, superparamagnetic 
behavior can be observed. Energy input using superparamagnetic particles 
and a field of 77 kHz and 6.5 kA/m (acceptable by the patient) is high enough 
to increase the temperature of the cement 7 °C of maximal 1 cm distance 
from the implant and after a short treatment of 30 to 60 min. The efficiency 
of the magnetic field, the increase of temperature in the tissue during the 
MFH therapy, is strongly dependent on the size and shape as well as the 
effect of biocompatible coatings of the superparamagnetic particles. The most 
effective particles are monodisperse, showing a diameter of 9 – 12 nm and 
are elongated in the direction of the easiest magnetization. The biocompatibility 
is guaranteed by its coating with silica which leads finally to so called 
micobeads, a composite of silica with a high (30 vol%) iron oxide.  Preliminary 
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result show that in vitro, alternating magnetic fields induced a high 
temperature increase to over 60°C. Taking potential clinical applications into 
account, an optimal frequency of 141 kHz and a magnetic field strength 
between 6 and 12 mT were chosen. Mixtures of above mentioned 
nanoparticles embedded in silica were incorporated at the highest (still 
injectable) concentration in several embolization formulations. For in vivo 
tests, Swiss nude mice were grafted subcutaneously with human 
colocarcinoma Co112. The formed tumor was injected with 0.25 ml of a 
mixture of poly(ethylene-co-vinyl alcohol) in dimethyl sulfoxide containing 
40% nanopareticles embedded in silica.  The implant was injected and 
hyperthermia was performed for 20 minutes the following day, checking 
continuously peripheral, implanted tumoral and superficial cutaneous 
temperature by fluoroptic probes. First experiments showed intratumoral 
equilibrium temperatures of 40.4, 43.0 and 44.5°C with a variability of the 
measured temperatures smaller than ±10 % at 9, 10 and 10.5 mT, respectively 
(N = 4 mice per group). Mice were euthanized after two days for standard 
histology. This short-term protocol addresses mainly hyperthermia cytotoxic 
effects. Reported intratumoral temperatures correlated with histological 
results. Clearly, heat induced necrosis occurred when steady-state 
temperature exceeded 42.5°C (Fig. 10). Together with an industrial investor, 
the inventor of the system has founded a company for further exploitation of 
these results. 
 
 
 
Figure 10. Histology of a treated tumor showing slight inflammatory necrosis close to 
the brownish implant. The skin on the left of the implant displays stigmas of heat 
exposition. 
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3.3.2. Tissue soldering 
 Simplification and optimization of vascular bypass procedures is the 
main goal of all new anastomosis techniques, such as laser, biochemical or 
electromagnetic welding and soldering. In close cooperation with the 
Inselspital Bern, (Dr. M. Reinert) experiments with an alternating magnetic 
field on superparamagnetic iron oxide nanoparticles (SPIONs), figuring as 
energy transmitters, were performed. SPIONs were tested for their 
electromagnetic heating capability in an albumin solder solution alone and 
thereafter used as energy transmitters for soldering the adventitial layer of 
rabbit aortic tissue slices. Temperature profiles and rupture forces of the 
fused vascular tissue were measured and histological analyses were 
performed. The experiments clearly revealed the feasibility of tissue fusion 
by applying electromagnetic fields. The force of rupture was between 2600 
and 3700 mN. Therefore, electromagnetic tissue soldering is a promising 
technique for vascular tissue fusion. Both particularly robust rupture forces 
and histological assessment profiles were achieved using SPIONs as energy 
transmitters. A patent was applied for and a publication is in preparation. 
 
4. Intercellular tracking of biomarkers 
4.1. Particle library/separation 
 The developments of the authors also includes techniques and devices for 
using SPIONs for use in targeting and magnetic extraction of cellular 
compounds and their chemical, optical, and physical analysis including 
proteomics. This use of functional nanoparticles enables identification of 
their specific interaction partners in a physiological environment, such as the 
entire intact cell. Proteomic analysis of diseases, where the immobilized 
interaction partner reacts with the target in physiological conditions, is 
possible as well as synthesis of peptide and molecule libraries for the 
determination of interaction partners. In contrast to all other techniques, 
interaction partners can be identified in physiological conditions in the cell. 
 We demonstrated that functionalized nanoparticles smaller than 100 nm 
carrying simultaneously specific organelle addressing peptides, a cyclic RGD 
peptide and a fluorescent dye are able to localize specifically at the target site 
(publication in preparation, patent applied). Nucleus and mitochondria were 
studied and in situ affinity chromatography was performed. In order to study 
particle-organelle interactions, we separated the cell lysate on a magnetic 
separator after the particle incubation with live cells and lysation of the cells. 
This cell separator has a strong magnetic field gradient of several hundred 
T/m. After protein electrophoresis, the analysis by mass spectroscopy 
revealed mitochondrial and nuclear proteins in magnetically enriched fractions.  
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 To investigate how functionalized SPIONs interact with cell organelles, 
we covalently bound maleimide-PEG-NHS to amine groups of aminopropylsilica 
surface of the particle core generating PEG-SPIONs leaving maleimide group 
of the PEG for coupling of the fluorophores and peptides via thiol group. In 
order to assess the efficiency of mitochondrial targeting, three types of 
particles were functionalized by coumarin, c[RGDfK-(Ac-SH)] peptide 
and/or N-terminal 21 residues peptide from mitochondrial 3-oxoacyl-
Coenzyme A thiolase (MTP) giving rise to the MTP-SPION, MTP-cRGD-
SPION and cRGD-SPION, respectively. The evaluation of nuclear targeting 
employed two types of nanoparticles: the NTP-SPION were functionalized 
by FITC and PKKKRKV-GC peptide representing SV40 large T-antigen 
nuclear localization signal peptide (NTP) and the NTP-cRGD-SPION 
contained conjugated cRGD peptide in addition. After final synthesis step, 
functionalized particles showed size distribution in the range 70-100 nm.  
 The cells were lysed after incubation with the nanoparticles and mass 
spectrometric analysis of the proteins associated to magnetically sedimented 
complexes was performed. The detected proteins on the surface of MTP-
cRGD-SPION can be subdivided into several classes: i), proteins associated 
directly in the transport of the nanoparticles to their target site (heat shock 
proteins); ii), proteins associated to the transport of the particles to the 
mitochondrial outer membrane; iii) proteins which are associated to the 
membrane of the mitochondria (e.g. ATP synthase); iv) proteins associated to 
the processing of the arriving signal in the mitochondria (e.g. hsp 60); v) 
proteins suggested being associated to the mitochondria, but proof was not 
fully given. Proteins belonging to the second part of glycolysis (GAPDH, 
enolase, Pyruvate kinase) were identified proteins. With this investigation, 
we successfully detected a tool for the investigation of the up-take 
mechanism, and also for screening of peptides and drugs. 
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